Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. LaMarquise Inc.
WARNING LETTER
•LaMarquise Inc.•June 8, 2018

LaMarquise Inc. – FDA Warning Letter, Jun 8, 2018

Record Details

The FDA inspected La Marquise, Inc.'s bakery and central kitchen from June 4-8, 2018, focusing on Ready-to-Eat (RTE) cream-filled eclairs. The inspection revealed serious violations of the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food rule (21 CFR Part 117), leading to a determination that food was adulterated under Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act due to insanitary conditions. Failure to comply with preventive controls is also prohibited by Section 301(uu). Key deficiencies included the firm's failure to prepare and implement a written food safety plan for RTE products, as required by 21 CFR § 117.126, which should address hazards like environmental pathogens and food allergens. Additionally, several Current Good Manufacturing Practice violations were observed: equipment and utensils were not adequately cleanable or maintained (21 CFR 117.40(a)(1)); non-food contact surfaces were not cleaned sufficiently (21 CFR 117.35(e)); personnel failed to conform to hygienic practices, including improper handwashing and personal item storage (21 CFR 117.10(b)); and temperature controls for foods supporting rapid microbial growth were inadequate, with cooler records showing frequent temperature excursions (21 CFR 117.80(b)(3)). An FDA Form 483 was issued, but no response has been received. La Marquise, Inc. must promptly correct these violations and submit a written response within 15 working days, detailing corrective actions and prevention strategies. Failure to comply may result in regulatory actions such as seizure or injunction, and the assessment of re-inspection fees.

Company
LaMarquise Inc.
Inspection date
June 8, 2018
Product type
Food
Office
Division of Human and Animal Food Operations - East V
Person
  • Steven Barber (District Director at FDA)
View Company Profile

ID · eccb9466-d2b4-43cb-9f3f-ba68872ea0cd

Violation Codes10
21 CFR 11721 U.S.C. 342(a)(4)21 U.S.C. 331(uu)21 CFR 117.130(a)21 CFR 117.135(a)(1)21 CFR 117.12621 CFR 117.40(a)(1)21 CFR 117.35(e)21 CFR 117.10(b)21 CFR 117.80(b)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LaMarquise Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.